Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
deals
life sciences
microbiome
national blog main
new york blog main
new york top stories
pfizer
2
×
san francisco blog main
san francisco top stories
startups
abbvie
agtechfood
allergan aesthetics
alzheimer's disease
amgen
antibodies
astrazeneca
athira pharma
attralus
biologic drugs
biontech
boehringer ingelheim
boston top stories
boulder/denver
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
clostridium difficile
colostrum
covid-19
crohn's disease
cullinan oncology
cvs
What
microbiome
2
×
acquisitions
babies
biggest
bio
birth
born
breastfeed
build
buy
ceo
company’s
daniel
days
debut
drug
dyne’s
gilead
giving
gut
instructed
lands
milk
mothers
moves
openly
o’day
pantheryx
pipeline
produce
reason
roundup
sciences
scores
seagen
soon
spoken
target
there’s
they’re
Language
unset
Current search:
microbiome
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
